Carbomycin

CAS : 4564-87-8

Ref. 3D-AC19720

Informations sur le produit

• Nom: Carbomycin
• Synonymes: (12S,13S)-9-Deoxy-12,13-epoxy-12,13-dihydro-9-oxoleucomycin V 3-acetate 4B-(3-methylbutanoate)Carbomycin ACarbomycin, 4,17-Dioxabicyclo[14.1.0]heptadecane, leucomycin V deriv., 6-{[6-{[(1S,3R,7R,8S,9S,10R,12R,14E)-7-(acetyloxy)-8-methoxy-3,12-dimethyl-5,13-dioxo-10-(2-oxoethyl)-4,17-dioxabicyclo[14.1.0]heptadec-14-en-9-yl]oxy}-4-(dimethylamino)-5-hydroxy-2-methyltetrahydro-2H-pyran-3-yl]oxy}-4-hydroxy-2,4-dimethyltetrahydro-2H-pyran-3-yl 3-methylbutanoate (non-preferred name), 9-Deoxy-12,13-epoxy-9-oxoleucomycin V 3-acetate 4b-(3-methylbutanoate), Carbomycin A, Deltamycin A4, Deltamycin A₄, Leucomycin V, 9-deoxy-12,13-epoxy-12,13-dihydro-9-oxo-, 3-acetate 4^B-(3-methylbutanoate), (12S,13S)-, M 4209, Magnamycin A, NSC 51001, NSC 55924

Description

Carbomycin is a broad-spectrum antimicrobial agent that inhibits the growth of a wide variety of bacteria. It is active against many Gram-positive and Gram-negative bacteria, such as Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Klebsiella pneumoniae, and Escherichia coli. Carbomycin has been shown to be effective in treating infectious diseases caused by these bacteria. The antimicrobial activity of carbomycin is due to its ability to inhibit the synthesis of proteins essential for bacterial cell division. This drug binds to the enzyme ribosomal peptidyl transferase, which catalyzes peptide bond formation during protein synthesis. Carbomycin also binds to the enzyme methionine synthase, which catalyzes the conversion of homocysteine into methionine. Carbomycin's binding to these enzymes prevents them from functioning properly and leads to bacterial death by inhibiting protein synthesis.br

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 841.98 g/mol
• Formule: C₄₂H₆₇NO₁₆
• Degré de pureté: Min. 95%